Skip to main content
  • Conference proceedings
  • © 1985

Dyskinesia

Research and Treatment

Part of the book series: Psychopharmacology Series (PSYCHOPHARM, volume 2)

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (27 papers)

  1. Front Matter

    Pages I-IX
  2. Preclinical Aspects

    1. Front Matter

      Pages 1-1
    2. Receptor-Binding Profiles of Neuroleptics

      • J. Hyttel, J.-J. Larsen, A. V. Christensen, J. Arnt
      Pages 9-18
    3. Functional Classification of Different Dopamine Receptors

      • U. Ungerstedt, M. Herrera-Marschitz, L. StÃ¥hle, U. Tossman, T. Zetterström
      Pages 19-30
    4. Influence of GABA Mimetics and Lithium on Biochemical Manifestations of Striatal Dopamine Target Cell Hypersensitivity

      • B. Scatton, D. Fage, A. Oblin, B. Zivkovic, S. Arbilla, S. Z. Langer et al.
      Pages 39-45
  3. Clinical Aspects

    1. Front Matter

      Pages 63-63
    2. Is Tardive Dyskinesia a Unique Disorder?

      • C. D. Marsden
      Pages 64-71
    3. Tardive Dyskinesia: Prevalence, Incidence, and Risk Factors

      • J. M. Kane, M. Woerner, J. Lieberman
      Pages 72-78
    4. Chemical and Structural Changes in the Brain in Patients with Movement Disorder

      • A. J. Cross, T. J. Crow, I. N. Ferrier, J. A. Johnson, E. C. Johnstone, F. Owen et al.
      Pages 104-110
    5. Medical Treatment of Dystonia

      • H. Pakkenberg, B. Pedersen
      Pages 111-117
    6. GABA Dysfunction in the Pathophysiology of Tardive Dyskinesia

      • C. A. Tamminga, G. K. Thaker, T. N. Chase
      Pages 122-127
    7. Clinical Activity of GABA Agonists in Neuroleptic- and L-Dopa-Induced Dyskinesia

      • P. L. Morselli, V. Fournier, L. Bossi, B. Musch
      Pages 128-136

Editors and Affiliations

  • Medical Research, Psychiatry and Neurology Services at the Veterans Administration Medical Center, USA

    Daniel E. Casey

  • Departments of Psychiatry and Neurology at the Oregon Health Sciences University, Portland, USA

    Daniel E. Casey

  • Oregon Regional Primate Research Center, Beaverton, USA

    Daniel E. Casey

  • Intramural Research Program, National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, National Institute of Health, Bethesda, USA

    Thomas N. Chase

  • H. Lundbeck A/S, Copenhagen-Valby, Denmark

    Anne Vibeke Christensen

  • Department AEH, Sct. Hans Mental Hospital, Roskilde, Denmark

    Jes Gerlach

Bibliographic Information

  • Book Title: Dyskinesia

  • Book Subtitle: Research and Treatment

  • Editors: Daniel E. Casey, Thomas N. Chase, Anne Vibeke Christensen, Jes Gerlach

  • Series Title: Psychopharmacology Series

  • DOI: https://doi.org/10.1007/978-3-642-70140-5

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1985

  • Softcover ISBN: 978-3-642-70142-9Published: 23 November 2011

  • eBook ISBN: 978-3-642-70140-5Published: 12 March 2013

  • Series ISSN: 0931-6795

  • Edition Number: 1

  • Number of Pages: X, 230

  • Topics: Pharmacology/Toxicology, Neurology, Internal Medicine, Pathology

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access